Loading...
Hallo, wie können wir Ihnen helfen?

Dr. Shivadasan ANOOP

Over 16 years of experience, my expertise spans various scientific disciplines, including teaching, surgery, toxicology, breeding, immunology, regenerative medicine, pathology, and physiology. Throughout my veterinary internship and professional career, I have held roles such as attending veterinarian, study director, manager, research assistant, and department head, contributing to specialized areas like surgical procedures, sampling, substance administration, breeding, treatment, behavior assessment, safety pharmacology (telemetry), euthanasia, necropsy, and animal welfare. My experience covers a diverse range of species, including dogs, rabbits, guinea pigs, cats, rats, mice, ferrets, Japanese quail, pigeons, zebrafish, goats, sheep, pigs, mini-pigs, cattle, and non-human primates.

Professional Summary

A high-level overview of expertise, including:
• Laboratory Animal Science Expert, Attending Veterinarian, Toxicologist and Expert Surgeon

• Established India’s first commercial CCSEA approved beagle dog breeding facility (Isoquimen India / Palamur Biosciences Pvt. Ltd. )

• Initiated and founded the pre-clinical and non – clinical platform for the non-rodent division of Pharmacokinetic and Toxicokinetic studies at Palamur Biosciences Pvt. Ltd. comprising different species like dog, mini-pig, pig, NHP and Cattle etc.

• Established the Safety Pharmacology – Telemetry division at Palamur Biosciences Pvt. Ltd.

• One of the main contributors in the setting-up of the medical devices testing and training division of Palamur Biosciences, which is established under the aegis of National Biopharma Mission (NBM) and BIRAC

• Preclinical and regulatory toxicology expertise across multiple sectors (pharmaceuticals, chemicals, medical devices, food safety, environmental toxicology)

• Experience with non-clinical study design and management, including in vivo and in vitro studies

• Toxicological risk assessments (e.g., PDE-OEL, leachable/extractables, genotoxicity, impurities, ecotoxicology)

• Expertise in drug development pathways (IND, NDA, ANDA – 505(j), 505(b)2 applications)

• Regulatory experience with global agencies (USFDA, EMA, CDSCO, ANVISA, CFDA, TGA, MFDS, etc.)

• Leadership skills (managing CRO collaborations, regulatory responses, preclinical study oversight